S.A. Mason’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-905
Closed -$84.3K 315
2022
Q4
$84.3K Hold
905
0.06% 219
2022
Q3
$86K Hold
905
0.07% 212
2022
Q2
$84K Sell
905
-56
-6% -$5.46K 0.06% 219
2022
Q1
$97K Hold
961
0.06% 222
2021
Q4
$99K Hold
961
0.06% 215
2021
Q3
$82K Buy
961
+250
+35% +$20.9K 0.05% 227
2021
Q2
$59K Hold
711
0.04% 239
2021
Q1
$53K Hold
711
0.04% 236
2020
Q4
$49K Buy
+711
New +$46.2K 0.04% 229
2020
Q2
Sell
-121
Closed -$7K 308
2020
Q1
$7K Buy
121
+55
+83% +$3.67K 0.01% 337
2019
Q4
$5K Buy
+66
New +$4.63K ﹤0.01% 379

Other funds holding CVS

S.A. Mason's CVS Position: Q1 2023 in Review

S.A. Mason sold out of CVS Health (CVS) in Q1 2023, closing a stake of 905 shares — an estimated $84.3K sold.

S.A. Mason first reported a position in CVS in Q4 2019 and held it in 11 quarters. The position peaked at $99K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • S.A. Mason reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • S.A. Mason sold 905 CVS Health shares in Q1 2023, an estimated $84.3K.
  • S.A. Mason first reported a position in CVS Health in Q4 2019 and held it in 11 quarters.
  • S.A. Mason's CVS Health position peaked at $99K in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on S.A. Mason's 13F filing for Q1 2023, filed 10 May 2023.